SCIEX launches the Citrine™ Triple Quad™ MS/MS Systems in Europe, bringing maximal speed and sensitivity to clinical diagnostics testing

The SCIEX Citrine™ MS/MS medical device provides clinical labs with one solution to tackle today's difficult assays, and the versatility to address tomorrow’s precision medicine and wellness testing

Darmstadt, Germany — SCIEX Diagnostics, the in vitro diagnostics division of SCIEX, a global leader in mass spectrometry in the life sciences industry, is launching the Citrine™ Triple Quad™ MS/MS and Citrine™ QTRAP® MS/MS systems for clinical diagnostics at Analytica 2018, from April 10-13 in Munich, Germany. The Citrine system is designed specifically to meet the unique needs of clinical labs that require maximum sensitivity, the highest throughput, a wide dynamic range, and the ability to employ simplified sample preparation. This high performance mass spectrometry technology will be available at the SCIEX booth in hall A2, booth #317, throughout the show.

The unique combination of sensitivity and speed offered by the Citrine MS/MS system makes this the ideal choice for the clinical laboratory, enabling trace level analysis, comprehensive panels, and the measurement of both large and small molecules. Triple quadrupole and QTRAP models of the system are available, each offering ultimate sensitivity to enable the measurement of metabolites and biomarkers at picomole concentrations. In addition, the exclusive QTRAP technology enables unique workflows, providing quantitative and qualitative analysis in a single injection, and allowing the use of highly selective MRM3 quantitation to eliminate interferences.

The system is powered by the familiar Analyst®MD software, for intuitive instrument control and data processing. The second generation IonDrive™ Turbo V ionisation source provides robust, reliable performance when analysing even the most complex biological samples, maximises uptime, and enables the use of simpler sample preparation strategies.

"The Citrine MS/MS system delivers the legendary robustness and reliability of a SCIEX mass spectrometry solution, but also provides clinical laboratories with the necessary performance to address the most challenging clinical applications," said Dr Aaron Hudson, Vice President and GM of SCIEX Diagnostics. "The speed and sensitivity of the system translate into meaningful advantages for our customers, who are always trying to do more with less. Not only can clinical labs expand their capabilities by bringing testing in-house and developing their own lab developed tests (LDT), they can also achieve faster run-times, develop highly multiplexed panels to increase laboratory efficiency, and take advantage of simplified sample preparation to reduce costs and labour.&quot

The system offers electrospray ionisation (ESI) and atmospheric chemical ionisation (APCI) options, an extended mass range up to m/z 2000, and a wide linear dynamic range, making this a versatile tool for the measurement of a large variety of polar and non-polar biomarkers and metabolites in biological fluids, over a large range of concentrations.

Citrine MS/MS follows the 2017 introduction of the Topaz™ system, a fully integrated LC-MS/MS platform, driven by ClearCore™ MD Software. The new and intuitive software is designed specifically for use in clinical labs. SCIEX will be providing live presentations of its unique clinical IVD software for the Citrine and Topaz Systems on the company's booth at Analytica. Interested participants should contact SCIEX via email to analytica2018@sciex.com in order to schedule a meeting.

To learn more about the SCIEX Citrine System, view our website at https://sciex.com/diagnostics, visit the SCIEX booth (#317 in hall 2) at Analytica 2018.